Objectives This study tested hypotheses drawn from a risk model positing that psychosocial risk plus disease-related and treatment factors contribute to bulimic symptoms in youth with type 1 diabetes (T1D) transitioning to an insulin pump. The goal of this study was to examine whether diseaserelated factors, particularly disease-and treatment-based disruption in hunger and satiety, contribute to report of bulimic symptoms in youth with T1D after accounting for psychosocial risk factors. Methods 43 youth (ages 10-17, 54% female) with established T1D were recruited before transition from multiple daily injections to insulin-pump therapy from three tertiary pediatric diabetes centers. Participants completed measures of bulimic symptoms, depressive symptoms dietary restraint, and the Diabetes Treatment and Satiety Scale, a diabetes-specific questionnaire assessing hunger and satiety cues and eating behavior in response to blood glucose levels and treatment. Results Hierarchical multiple regression was used to assess contributions of psychosocial and disease-based risk to report of bulimic symptoms. After assessing the contributions of body mass index, body image dissatisfaction, and dietary restraint, a significant 2-way interaction emerged between depression and diabetesrelated uncontrollable hunger related to bulimic symptoms (b ¼ 1.82, p < .01). Conclusions In addition to psychosocial risk, disease-and treatment-based hunger and satiety dysregulation appear to be important factors contributing to report of bulimic symptoms in youth with T1D. These preliminary findings have significant treatment implications for bulimic symptoms in youth with T1D.
Adolescents with type 1 diabetes (T1D) have higher rates of bulimic symptoms as compared with their peers without T1D , and these symptoms are often associated with higher rates of diabetes-related health complications (Goebel-Fabbri et al., 2008; Scheuing et al., 2014) . Symptoms include dietary restriction, binge eating (the consumption of objectively large amounts of food with loss of control), purging, fasting, and excessive use of physical activity (Rosen, 2003) . Bulimic symptoms in the T1D population may include these behaviors as well as insulin restriction or omission, a unique and discrete form of purging calories via intentional hyperglycemia and glycosuria (i.e., purging of calories; GoebelFabbri et al., 2008) . Additionally, binge eating is one of the most common disordered eating symptoms in youth with T1D (Colton, Olmsted, Daneman, Rydall, & Rodin, 2004) . Youth with T1D and co-morbid eating disorder symptoms are reported to have A1c values as much as 2 points higher than youth with T1D and without eating disorder symptoms (Affenito et al., 1997) , underscoring the impact on clinical outcomes. Models of risk for bulimic symptoms have generally focused solely on otherwise healthy individuals and have not been validated in youth with co-occurring T1D. The purpose of this study is to examine a proposed risk model that incorporates both psychosocial and physiological (disease-and treatment-related) risk for the development of bulimic symptoms in a sample of youth with T1D transitioning to an insulin pump regimen. We specifically aim to examine the role of proprioception of hunger and satiety as a unique risk factor for bulimic symptoms assessed with traditional self-report instruments in youth with T1D.
The Dual Pathway Model
The dual pathway model (Stice, 2001 ) is a psychosocial risk model for the development of disordered eating, specifically symptoms of bulimia. The model proposes that weight gain following puberty leads to increased body dissatisfaction, and in turn, increased body dissatisfaction influences the development of both dieting and negative affect. Both have been shown to lead to the development of binge eating and inappropriate compensatory behavior (Allen, Byrne, & McLean, 2012) . Thus, the dual pathway model explains psychosocial risk for bulimic symptoms and is a useful framework for understanding the onset of bulimic symptoms during adolescence. However, the model does not account for diseaseand treatment-based factors in T1D that have the potential to dysregulate eating. The Modified Dual Pathway Model (see Figure 1) integrates psychosocial risk factors with physiological processes and treatment-based factors, and proposes that youth with T1D could have bulimic symptoms driven by psychosocial factors, disrupted eating related to disease processes and treatment, or some combination of both (Peterson, Fischer, & Young-Hyman, 2014 ).
The Modified Dual Pathway Model
Insulin treatment, attendant weight gain, and food preoccupation (e.g., carbohydrate counting) are previously hypothesized mechanisms through which the treatment of T1D may increase vulnerability to bulimic symptoms (Daneman, Olmsted, Rydall, Maharaj, & Rodin, 1998) . Weight gain typical of pubertal development can be exacerbated in adolescents with T1D because of rebound adiposity following initiation of insulin treatment in those diagnosed during puberty, the developmental stage with the highest incidence rate (Helgeson, Siminerio, Escobar, & Becker, 2009 ). This weight gain (which often accompanies achievement of good glycemic control) could play a role in the development of body dissatisfaction in adolescents with T1D (Olmsted, Colton, Daneman, Rydall, & Rodin, 2008) .
The treatment of T1D is complex and requires monitoring of one's eating (e.g., carbohydrate counting), blood glucose levels, activities, and reactive insulin and food adjustments. The Modified Dual Pathway Model posits that disease processes (including duration) and treatment-based disruption to hunger and satiety cues secondary to insulin treatment and fluctuations in blood glucose increase the risk for disrupted eating behavior (Lutz, 2005) , which mimics bulimic symptoms. For example, hypoglycemic episodes can be associated with excessive hunger and caloric intake (Merwin et al., 2014) . To reduce the effects of excessive hunger and caloric intake on weight, subsequent compensatory insulin restriction may be used, causing glycosuria (Tortora & Nielsen, 2009 ). Goebel-Fabbri (2009 outlined an important theoretical risk model incorporating insulin misuse in T1D with disturbed eating behaviors. This is distinct from the Modified Dual Pathway Model, which is instead focused on the role of physiology related to T1D (insulin increasing hunger cues, poor hunger and satiety proprioception, and fluctuations in blood glucose) as a risk for symptoms that mimic bulimic symptoms.
Treatment Type
Treatment modality for T1D may also impact the influence of disease processes on bulimic symptom presentation. Treatment modalities include multiple daily injections (MDI) and continuous subcutaneous insulin infusion pumps (Pump), and the prevalence of bulimic symptoms is similar across treatment modalities (e.g., MDI vs. Pump; Battaglia, Alemzadeh, Katte, Hall, & Perlmuter, 2006; Prinz et al., 2016) . Of note, individuals approved for an insulin pump may represent a distinct group that has previously been described as more likely to be non-Hispanic white and of a higher socioeconomic status (Paris et al., 2009 ). These cultural factors may also influence disordered eating presentation in these youth. Youth with bulimic symptoms on pump regimens are more likely to discontinue pumps as compared with youth without bulimic symptoms (Prinz et al., 2016) . Another study found that after 6 months of using the pump, bulimic symptoms were improved (Markowitz, et al., 2013) . Thus, the literature on the interaction of ongoing pump treatment with bulimic symptom presentation is mixed.
Initiation of a pump regimen is a particular time of interest to study in conjunction with bulimic symptoms. As many youth transitioning to pump treatment have already been treated for T1D, they may have heightened awareness of the impact of physiological variations on eating behaviors. Additionally, this group of youth has already experienced weight-regain due to previous treatment. Binge eating is a commonly reported symptom in youth with T1D (Colton et al., 2004) . Hypoglycemia is often experienced by youth who have had unsuccessful regulation of blood glucose with insulin injections (Markowitz, et al., 2013) . Hypoglycemia disrupts self-regulation (Gailliot & Baumeister, 2007) , leads to increased hunger, and can result in loss of control over eating. Thus, both emotional factors and disrupted hunger and satiety may increase vulnerability to binge eating in this population of youth with T1D. In summary, youth already managing T1D with multiple daily injection therapy are a population in which several risk factors identified in the Modified Dual Pathway Model are already in place: weight re-gain, a focus on diet, and physiological disruption of hunger and satiety. The effects of physiological disruption of hunger and satiety on binge eating may be best assessed in a cross-sectional design. As some data suggest that bulimic symptoms improve following several months of pump treatment (Markowitz et al., 2013) , it is possible that this intervention increases regulation of hunger and satiety and thus reduces the impact of this proposed risk factor on self-report disordered eating.
The Current Study
The current study tested hypotheses generated from the Modified Dual Pathway Model (Peterson et al., 2014) in a sample of youth with T1D intending to transition from multiple daily injection treatment to pump treatment. Namely, we tested the hypothesis that disease-based factors contribute to reports of current bulimic symptoms in this population. Importantly, our theoretical model emphasizes the role of physiological disruptions to hunger and satiety on behaviors that mimic bulimic symptoms as assessed by traditional eating disorder self-report measures. Thus, this analysis serves as a proof-of-concept test of hypotheses drawn from this model, not as a vehicle for establishing pathological uses for self-management of diabetes symptoms. We chose to select participants transitioning to pump and use a cross-sectional design because this period allows us to test the impact of both psychological and/or disease-based variables on current bulimic symptoms. Further, a cross-sectional design is an important first step to provide preliminary data on the Modified Dual Pathway Model (proof of concept) before testing it in a prospective design. We examined the unique contributions of variables delineated by the proposed model (length of illness, glycemic control [A1c], dietary restraint, body dissatisfaction, depression, and disease-based hunger and satiety indicators) to bulimic symptoms as assessed by the Eating Disorder Inventory-III (EDI-III) Bulimia subscale (Garner, 2004) . The use of a wellvalidated measure of eating disorder symptoms was important because we wanted to show the unique contribution of disrupted hunger and satiety secondary to T1D in the prediction of bulimic symptoms. We chose not to assess insulin restriction because we wanted to understand how much T1D-related physiologic symptoms accounted for variance in a traditional eating disorder measure. We hypothesized that known risk factors for bulimic symptoms including body dissatisfaction, dietary restraint, and depression would account for significant variance in bulimic symptoms. Additionally, we hypothesized that after controlling for the effects of psychosocial risk factors, glycemic control and uncontrollable hunger would account for unique variance in bulimic symptoms in this sample of youth with T1D.
Methods

Participants
For purposes of this study, we recruited participants who were on a multiple daily injections (basal bolus) regimen and evaluated within 10 days of initiation of insulin pump therapy. Participants (n ¼ 43) were 54% female, between the ages of 10 and 17 (12.86 6 1.83) years, and had a mean duration of T1D of 4.3 6 3.5 years. The majority of the sample was Caucasian (75.2%), with 21.8% African American, and 3% identified as another ethnicity. The participation of an eligible caregiver (person with whom the child/adolescent spends at least 50% of their time and had responsibility for overseeing T1D management) was also required. Exclusion criteria included unstable medical conditions affecting weight (e.g., gastrointestinal or adrenal disorder), a severe psychiatric illness that would significantly affect the individual's ability to follow the T1D treatment regimen (e.g., psychotic disorder), a disorder that affects metabolism, and if female, pregnancy.
Procedure
Members of the diabetes health care team referred patients or patients were identified from clinic/study rosters based on eligibility criteria and were approached by research assistants. Participants were recruited from three different sites: Augusta University in Augusta, GA; Emory University in Atlanta, GA; and Joslin Diabetes Center in Boston, MA. Assessments were conducted with the child and primary caregiver when the child/family was being evaluated before initiation of insulin pump therapy. All participants, both adolescents and caregivers, were compensated with a $25 gift card.
Measures
Demographic Information Form
Parents completed a Demographic Information Form at the initial visit to obtain date of birth, gender, and composition of the family. Information about the child's medical history was collected from the parent.
Eating Disorder Inventory-III
The EDI is a widely used self-report measure of eating disorder symptoms and consists of eight standardized subscales representing dimensions that are clinically relevant to eating disorders, including the bulimia and body image dissatisfaction subscales (Garner, 2004) . The EDI-III uses a 0-4-point scoring system. The bulimia subscale scores range from 0 to 32 and the body dissatisfaction subscale scores range from 0 to 32, with higher scores indicative of more symptoms. Previous studies have used the EDI to examine eating disorder symptoms in youth with T1D (Jones, Lawson, Daneman, Olmsted, & Rodin, 2000; Takii et al., 2003 Takii et al., , 2011 . Further, we chose to use a traditional eating disorder assessment tool because we wanted to understand how much disruptions to hunger and satiety related to T1D physiology and treatment were associated with traditional eating disorder symptoms. Acceptable convergent validity for the EDI-III with other valid and reliable measures of eating pathology has been established in prior studies (Cumella, 2006) . Internal consistency was acceptable for the bulimia subscale (a ¼ .83) and body image dissatisfaction subscale (a ¼ .80) in the current sample.
A1c
Hemoglobin A1c laboratory assay values were obtained from study participant charts. Methods for obtaining these assays were consistent with standards established by The Diabetes Control and Complications Trial (DCCT). The DCCT was a prospective randomized controlled trial investigating intensive versus standard glycemic control in patients with T1D (DCCT, 1993; Little, 2003) .
Body Mass Index
Height and weight were measured at the research baseline assessment, or obtained from the participant's medical record when they were seen that same day for a medical appointment. When directly measured, three measurements of height and weight were obtained, and then averaged. Sex-and age-adjusted body mass index (BMI) (BMI z-score standard deviation [z-BMI] based on the Centers for Disease Control and Prevention [CDC] growth charts) were calculated (Kuczmarski & Flegal, 2000) .
Youth Risk Behavior Survey
The Youth Risk Behavior Survey (YRBS) is a crosssectional survey conducted biennially by the CDC to youth behaviors that influence health. For the current study, an item from this survey was utilized to assess dietary restraint; "During the past 30 days, did you eat less food, fewer calories, or foods low in fat to lose weight or to keep from gaining weight?"
The Children's Depression Inventory The Children's Depression Inventory (CDI) is used to assess cognitive, affective, and behavioral signs of depression in children and adolescents aged 6-17 years (Kovacs, 1992) . The CDI self-report measure consists of 27 items, and for the purposes of this study, a total score was utilized. Total scores range from 0 to 40. A raw score of 13 or higher is indicative of risk of clinical levels of depressive symptoms (Kovacs, 1992 ). In the current study, reliability for the CDI was adequate, a ¼ .80.
The Diabetes Treatment and Satiety Scale
The Diabetes Treatment and Satiety Scale (DTSS) is a 20-item measure used to assess hunger, satiety, and fullness in the context of food intake, insulin regimen, and blood glucose (Young-Hyman & Davis, 2010) . The six subscales include Uncontrollable Hunger, Remain Hungry, Low Blood Sugar, Feeling Full, Satiety, and High Blood Sugar. The DTSS-20 is internally consistent; shows criterion validity, distinguishing groups expected to differ on this measure; and is associated with related phenomena such as body size satisfaction and diabetes-specific disordered eating behavior (Young-Hyman, Davis, Looney, Grigsby, & Peterson, 2011) . The DTSS was used to assess eating behaviors that are associated with diabetes-related variables. In the current study, the Uncontrollable Hunger subscale (four items; a ¼ .76) was used to assess hunger associated with insulin and glucose balance related to treatment regimen. We were particularly interested in the relationship that uncontrollable hunger secondary to diabetes-related variables (e.g., overinsulinization and hypoglycemia) would have with bulimic symptoms given the theoretical rationale put forth by the Modified Dual Pathway model. The DTSS Uncontrollable Hunger subscale has shown acceptable criterion validity with other measures such as the Diabetes Eating Problems SurveyRevised (DEPS-R; Markowitz et al., 2010) .
Statistical Analyses
All analyses were conducted using IBM SPSS Statistics 21, Release Version 21.0. Consistent with recommendations put forth by Hawthorne, Hawthorne, and Elliot (2005) , missing data from self-report surveys were replaced using the mean of the items at the level of the individual (Hawthorne et al., 2005) . Of note, 47 youth enrolled in the study. However, we are only reporting data on 43 of the participants, as four participants did not complete questionnaires. Of the remaining questionnaire data, less than 1% were missing. Given the low number of missed responses, we used a mean substitution. T-tests were performed to evaluate potential differences among study sites, and t-tests to evaluate differences between males and females. Bivariate correlations were computed between risk variables, and risk variables and bulimic symptoms.
Hierarchical multiple regression was utilized to test the effects of disruption in hunger and satiety on bulimic symptoms when controlling for psychosocial risk factors (body image dissatisfaction, dietary restraint, and depressive symptoms). Participant sex, race, age, z-BMI score, A1c, length of illness, and site were entered in the first step. Additionally, we explored whether or not there was a quadratic relationship between z-BMI and bulimic symptoms, such that youth with the highest and lowest BMIs may be most likely to endorse symptoms. To do this, we created a squared z-BMI term that was added to the regression model (Cohen, Cohen, West, & Aiken, 2013) . In the second step, depressive symptoms, dietary restraint, body image dissatisfaction, and DTSS uncontrollable hunger were entered. Finally, all two-way interactions were entered in the third step, including between depressive symptoms Â DTSS uncontrollable hunger, depressive symptoms Â body image dissatisfaction, and DTSS uncontrollable hunger Â body image dissatisfaction.
Results
Descriptive Statistics
Descriptive statistics can be found in Table I . A oneway ANOVA was conducted to determine if there were significant differences between sites where study participants were recruited. Ten (23.3%) of the participants were recruited from Augusta University, 13 (30.2%) from Emory, and 20 (46.5%) from Joslin. There were no significant differences between sites on bulimia [F (2, 40) ¼ 1. Female participants endorsed significantly higher scores on body image dissatisfaction as compared with males (t ¼ À2.19, p < .05). There were no significant sex differences within the sample in terms of age, A1c, z-BMI percentile, depressive symptoms, dietary restraint, DTSS, or bulimic symptoms.
Bivariate correlations between major variables of interest were conducted to test the hypothesis, and are presented in Table I . Bulimic symptoms were significantly correlated with the DTSS Uncontrollable Hunger scale (r ¼ .32, p < .05), z-BMI score (r ¼ .32, p < .05), body image dissatisfaction (r ¼ .32, p < .05), and depressive symptoms (r ¼ .32, p < .05). A1c was significantly associated with higher body image dissatisfaction (r ¼ .32, p < .05) but not bulimic symptoms (r ¼ .16, p > .05). Finally, body image dissatisfaction was significantly associated with depressive symptoms (r ¼ .71, p < .01).
Multiple Regression Analyses
In the model using all youth with A1c data (Table II, (Aiken, West, & Reno, 1991) revealed that a combination of high depression scores and high DTSS uncontrollable hunger scores was associated with the most bulimic symptoms See Figure 2 (Holmbeck, 2002) .
Discussion
The current cross-sectional, pilot study examined eating disorder risk factors delineated by Stice's Dual Pathway Model (i.e., body image dissatisfaction, dietary restraint, and depression; Stice, 2001) in conjunction with disease-based factors: A1c, duration of T1D, and disruptions in hunger and satiety. This crosssectional study was an important first step in providing preliminary data in support of the Modified Dual Pathway Model. Consistent with hypotheses, factors proposed by the Modified Dual Pathway Model (Peterson et al., 2014) were cross-sectionally associated with bulimic symptoms in a sample of youth who have had experience living with the disease and its treatment. After accounting for dietary restraint, body image dissatisfaction, and weight, the interaction of depression and uncontrollable hunger accounted for significant unique variance in bulimic symptoms. This finding underscores the importance of accounting for disruptions to hunger and satiety associated with T1D disease processes and treatment when assessing eating pathology in youth with T1D. Importantly, the aims of this article were to identify physiologic symptoms secondary to T1D that mimic bulimic symptoms. Thus, we did not include an assessment of insulin misuse, as it was beyond the theoretical scope of the article. Although these findings were cross-sectional in nature, they point to important associations between excessive hunger and bulimic symptoms in youth with T1D. A recent review highlights these issues as well, and hypothesizes that repeated loss of control over consumption may also perpetuate neurobiological changes in the brain related to food addiction (Treasure et al., 2015) . Bulimic symptoms reported by T1D youth may be physiologically driven, representing disrupted eating rather than psychopathological disordered eating behavior. The addition of appetite regulating hormones to the T1D treatment regimen has demonstrated reductions in over-eating and binge eating (Smith et al., 2007) . Reports of disordered eating behaviors in this population have been evaluated using instruments that presume a psychopathologic origin. Reporting of psychopathologic bulimic symptoms by patients with T1D is known to be problematic because of the implications for disease management and health (Goebel-Fabbri et al., 2008) . Framing disruption in eating behavior as an expected result of the disease and its treatment could help to elucidate the prevalence of disease-based disrupted eating versus psychopathologic disordered eating behavior in this population.
The lack of significant effects for body image dissatisfaction, dietary restraint, or weight in this sample is consistent with previous studies suggesting that youth with T1D and co-occurring bulimic symptoms present with fewer weight concerns and less dietary restraint as compared with aged-matched peers with bulimic symptoms (Powers et al., 2012) . For youth living with the disease and treatment regimen, experiences of hunger dysregulation related to hormonal deficits (e.g., loss of amylin), exogenous-insulinization, and blood glucose fluctuations may result in a loss of control over food intake, which when combined with depressive symptoms, is associated with increased report of bulimic symptoms independent of dietary restraint, body image dissatisfaction, and weight status. Traditional models of eating pathology do not account for disruptions in hunger and satiety and, therefore, may attribute more psychosocial causes to higher endorsement of bulimic symptoms (Peterson et al., 2014; Young-Hyman & Davis, 2010) .
Clinical Implications
These findings suggest that disruptions to hunger and satiety and depressive symptoms are important in conceptualizing and measuring risk for bulimic symptoms and non-psychosocially based disrupted eating in youth with T1D. Although we cannot imply causation because of our cross-sectional, pilot study, it appears important to determine if endorsement of bulimic symptoms is due to psychosocial risk factors, physiologically related factors, or both. The interaction of these factors suggests that for those youth screening positive for bulimic symptoms using general and T1D-specific measures, treatment should involve a multidisciplinary approach to appropriately address both psychological and physiological factors.
Given that our study supports the role of both physiological disruption to hunger and depressive symptoms in bulimic symptoms, treatment targeting both depressive symptoms and making adjustments to the medical regimen to reduce treatment-related effects on hunger are indicated. Previous studies have found support for the use of modified cognitive behavioral therapy (CBT) to treat bulimic symptoms in youth with T1D within the context of the treatment regimen (Reveler & Fairburn, 1992) . Recent shifts in T1D treatment afford more flexibility within the dietary regimen (ADA, 2010) . This flexibility is consistent with eating disorder treatments such as CBT, where rigid food rules are discouraged and more nonrestrictive attitudes toward eating are promoted (Wilson, Fairburn, Agras, Walsh, & Kraemer, 2002) . In addition to incorporating flexibility of meals and snacks, appropriate adaptations to the insulin regimen would be necessary (Goebel-Fabbri, 2009 ). Our findings suggest that reducing excessive hunger may reduce bulimic symptoms. (Although this needs to be examined in a longitudinal design.) Thus, improvements to the insulin regimen as well as more flexible dietary regimens and eating regular meals and snacks throughout the day are indicated. Cognitions regarding body image dissatisfaction, as well as fears of hypoglycemia, can also be targeted within this treatment modality. Given the role of depression in bulimic symptoms, a CBT approach should also target depressive symptoms. Depressive symptoms are the most commonly reported psychiatric problem for youth with T1D and are associated with poor glycemic control (Grey, Whittemore, & Tamborlane, 2002; Kovacs et al., 1997) . However, previous treatments for bulimic symptoms, including psycho-educational interventions and CBT, have not systematically addressed disease-based factors associated with insulin treatment and blood glucose (Reveler & Fairburn, 1992; Takii et al., 2003) , an important area for future intervention efforts.
Limitations and Future Directions
One limitation of the current study was the use of the EDI-III, which does not account for a T1D-specific form of purging, insulin manipulation. (Please see Goebel-Fabbri, 2009 , for a review of the role of insulin misuse in the context of T1D.) Several previous studies have used the EDI to assess eating disorder symptoms in youth with T1D (Jones et al., 2000; Powers et al., 2012; Takii et al., 2011) . Thus, we were interested in examining the relative contributions of dysregulated hunger to "standard" assessments of symptoms such as binge eating, such as this instrument. Many studies have reported higher rates of bulimic symptoms such as binge eating in the T1D population and this could in part be owing to not accounting for physiological disruption to hunger cues. Using a "standard" assessment of eating disorder symptoms allowed us to more clearly study the effects of dysregulated hunger on report of bulimic symptoms. However, we were not able to establish variables that contributed to the development of pathological use of insulin for weight and shape manipulation.
The current study was cross-sectional and therefore cannot determine the causal or directional nature of these variables regarding report of bulimic symptoms. Youth transitioning to pump are an ideal sample in which to test the role of hunger and satiety because they have been living with the illness and we would be likely to detect a stronger effect of dysregulated hunger and satiety on bulimic symptoms. We would expect that the onset of an insulin pump would actually regulate hunger and satiety over time, and subsequently decrease bulimic symptoms, an important study for future research. However, to test the hypothesis that hunger and satiety dysregulation is associated with bulimic symptoms in the context of other risk factors, a cross-sectional design was warranted.
Although this study examined a unique sample of youth transitioning to pump and allowed us to study variables proposed by the Modified Dual Pathway Model, prospective studies are needed to see how these variables change over time with an insulin pump, as it is more flexible and better mimics physiologic insulin. Given that insulin pumps better mimic endogenous insulin, it would be expected that individuals with T1D would experience less uncontrollable hunger and potentially less bulimic symptoms as a result. Prospective studies and laboratory-based experiments using well-characterized patients wherein blood glucose, insulin, and appetite regulating hormones are monitored/manipulated in relation to hunger, satiety, and food intake would further elucidate directionality and the relationship with putative disease-based factors and report of bulimic symptoms.
Findings should be interpreted with caution given our small sample size. Future studies with larger sample sizes and greater power should consider examining this model using path analysis. Given that the participants were transitioning to an insulin pump, we were unable to control for within-group differences regarding insulin administration and dosing. Further, youth with T1D who are transitioning to an insulin pump may represent a distinct group. Previous studies have shown that insulin pump users are more likely to be female, white, older adolescents, and have a higher socioeconomic status (Johnson, Cooper, Jones, & Davis, 2013; Paris et al., 2009) . Thus, future studies will need to compare individuals on a pump regimen with other treatment regimens to control for demographic and other selection factors. Additionally, height and weight were recorded by study assessors for some participants, and were obtained from medical records for other participants. Thus, the measurement method for these variables was not consistent across participants. However, height and weight were obtained by medical staff using standardized hospital procedures. We did not have data on hypoglycemia experience or meter downloads, but this would be an important area to examine in future studies, particularly as they relate to insulin dosing. Finally, in this study, our measurement of dietary restraint was limited to a single item, limiting the variability with which we could assess this behavior in our sample. However, previous studies have used single-item assessment methods for dietary restraint in samples of youth with T1D (Ackard, et al., 2008) .
Despite these limitations, the present study is novel in that it examined the putative role of T1D treatmentand disease-based factors in conjunction with known psychosocial risk factors for report of bulimic symptoms in a sample of youth with T1D. The present study demonstrated a relationship between disruptions in proprioception of hunger cues with reports of disordered eating when controlling for other known risk factors for bulimic symptoms. These results need replication in other T1D samples, and longitudinal studies are needed to examine the factors outlined by our model prospectively. The Modified Dual Pathway Model postulates that it is necessary to account for these disease-and treatment-related processes to avoid inaccurately attributing psychosocial causes for bulimic symptoms in this population.
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